Data for: Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis

Published: 25 February 2020| Version 1 | DOI: 10.17632/77m8fd3382.1
Contributors:
Hui-Zhi Zhang,
Xin Rui,
Hua-Feng Pan,
Ting-Ting Gu

Description

raw extracted data from all clinical trials

Files

Categories

Meta-Analysis

License